Clinical trial
Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea +…
NCT00150410 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00150410 |
|---|---|
| Title | Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose |
| Official title | A One-Year, Open, Randomized, Parallel, Three-Arm Study Comparing Exubera® (Insulin Dry Powder Pulmonary Inhaler) vs. Avandia® (Rosiglitazone Maleate) as Add-On Therapy vs. Exubera® Substitution of Sulfonylurea in Patients With Type 2 Diabetes, Poorly Controlled on Combination Sulfonylurea and… |
| Lead sponsor | Pfizer, Industry |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Inhaled insulin |
| Enrollment | 626 |
| Start date | Jan 1, 2003 |
| Completion | Jun 1, 2007 |
| First posted | Sep 8, 2005 |
| Last update posted | Oct 31, 2008 |
| Countries | Australia, Brazil, Canada, Mexico, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: